[1] Malloch D,Salk in IF.A new species of Scedosporium associated with osteom yelitis in humans [J].Mycotaxon,1984,21:247-255.
[2] Patrick RM,Ellen JB,Michael AP,et al.Manual of clinical microbiology [M].8th ed Washington ASM press,2003:1848-1856.
[3] Pedro I,Emilio PT,Luis P,et al.Disseminated infection and colonization by Scedosporium prolificans:a review of 18 cases 1990-1999 [J].Clin Infect Dis,2001,32(11):158-165.
[4] Gilgado F,Cano J,Gené J,et al.Molecular phylogeny of the Pseudallescheria boydii species complex:proposal of two new species [J].J Clin Microbiol,2005,43(10):4930-4942.
[5] 王思卜,张杰,余进,等.用ITS和TUB序列差异鉴定临床相关波氏假阿利什霉/尖端赛多孢 [J].中国检验医学杂志,2011,34(12):1084-1087.
[6] Kaltseis J,Rainer J,De Hoog GS.Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples [J].Med Mycol,2009,47(4):398-405.
[7] Zouhair R,Rougeron A,Razafimandimby B,Kobi A,et al.Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis [J].Med Mycol,2013,51(6):603-613.
[8] Lackner M,Rezusta A,Villuendas MC,et al.Infection and colonisation due to Scedosporium in Northern Spain.An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates [J].Mycoses,2011,54(3):12-21.
[9] Cuenca-Estrella M,Ruiz-Diez B,Martinez-Suarez JV,et al.Comparative in-vitro activity of voriconazole(UK-109,496)and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum [J].J Antimicrob Chemother,1999,43(1):149-151.
[10] Carrillo AJ,Guarro J.In vitro activities of four novel triazoles against Scedosporium spp [J].Antimicrob Agents Chemother,2001,45(7):2151-2153.
[11] Cuenca-Estrella M,Gomez-Lopez A,Mellado E,et al.In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi [J].Antimicrob Agents Chemother,2005,49(12):5136-5138.
[12] Lackner M,de Hoog GS,Verweij PE,et al.Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species [J].Antimicrob Agents Chemother,2012,56(5):2635-2642.
[13] Lackner M,Hagen F,Meis JF,et al.Susceptibility and diversity in the therapy-refractory genus Scedosporium [J].Antimicrob Agents Chemother,2014,58(10):5877-5885.
[14] 王澎,徐英春,窦洪涛,等.尖端赛多孢和多育赛多孢所致深部真菌感染2例并文献复习 [J].中国真菌学杂志,2007,2(4):210-213.
[15] 帕丽达·阿布利孜,Takashi Yaguchi,罗德梅,等.多育赛多孢菌性鼻窦炎1例-致病菌的鉴定和体外抗真菌药物敏感性研究 [J].中国真菌学杂志,2010,5(1):1-4.
[16] 万喆,余进,陈少杰,等.卡泊芬净联合伏立康唑、伊曲康唑或两性霉素B对尖端赛多孢子菌体外抑菌活性 [J].中国临床药理学杂志,2010,26(7):499-501.
[17] Cuenca-Estrella M,Alastruey-Izquierdo A,Alcazar-Fuoli L,et al.In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans [J].Antimicrob Agents Chemother,2008,52(3):1136-1139.
|